NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure.

Komarnicki, Pawel; Gut, Pawel; Musialkiewicz, Jan; Cieslewicz, Maja; Maciejewski, Adam; Patel, Prachi; Mastorakos, George; Ruchala, Marek

Komarnicki, Pawel; Gut, Pawel; Musialkiewicz, Jan; Cieslewicz, Maja; Maciejewski, Adam; Patel, Prachi; Mastorakos, George; Ruchala, Marek.

Afiliação

Komarnicki P; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Gut P; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Musialkiewicz J; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Cieslewicz M; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Maciejewski A; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Patel P; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Mastorakos G; Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Ruchala M; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.

Endocr Connect ; 12(10)2023 Oct 01.

Article em En | MEDLINE | ID: mdl-37552533

Palavras-chave

NT-proBNP; biomarkers; carcinoid heart disease; carcinoid syndrome; neuroendocrine tumors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Endocr Connect Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google